The IAEA's Nuclear Sciences and Applications Laboratories in Seibersdorf are upgrading their technical capacity for radiation medicine services with the acceptance testing of a new High Dose Rate (HDR) Brachytherapy System. Housed in the Dosimetry Laboratory, the HDR Brachytherapy System will join the existing laboratory irradiators in the IAEA's portfolio for providing calibration services to Member States. Donated to the laboratory by the Federal Republic of Germany, the new HDR Brachytherapy System is one of several pieces of equipment contributed to the laboratories through the Renovation of the Nuclear Applications Laboratories (ReNuAL) Project*.
"This is an important new capability for the laboratory," said Joanna Izewska, Head of the Dosimetry Laboratory, "With the expansion of our technical capacity, we will be in a position to more fully respond to Member State needs for services in HDR brachytherapy calibrations and promote the development of procedures to improve the accuracy of dosimetry for brachytherapy globally."
The IAEA's expansion to HDR brachytherapy technology will complement its existing brachytherapy service for Low Dose Rate (LDR) Caesium-137 brachytherapy sources. When the IAEA's LDR service was established nearly ten years ago, Cs-137 sources were widely used for brachytherapy treatment. However, use of these LDR sources has been gradually replaced by HDR brachytherapy based on Iridium-192 or Cobalt-60, capable of emitting higher levels of radiation intensity and maintaining several practical, clinical and radiation protection advantages. With over 1,300 HDR brachytherapy units in operation worldwide, it is the most common form of brachytherapy.